The Quantellect read.As of Nov 19, 2026, 9 active firms cover Baxter International Inc: 1 rate it Buy or better, 6 sit at Neutral, and 2 rate it Sell or worse, a neutral consensus. Targets span $15.00 to $29.00, a moderate spread. The average target of $23.56 sits 10% below the current $26.16. Sentiment has cooled somewhat, with Sell ratings rising from 1 to 2 over recent months. On the fundamentals, the Street sees revenue growth near 1% this year and 2% next, consensus EPS building from about $0.41 next quarter toward $2.05 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS9 active firms
Neutral
Strong Buy00%
Buy111%
Neutral667%
Sell222%
Strong Sell00%
Based on 9 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$23.56
-9.9% downside
Average target across 9 active firms as of Nov 19, 2026 vs $26.16 current
Highest Target$29.00
Average Target$23.56
Lowest Target$15.00
Detailed analyst forecasts for BAX
Showing 1–8 of 8 named analysts shown · 9 active firms in the rating projection
As of Nov 19, 2026, 1 of 9 active firms rate BAX a Buy (6 Neutral, 2 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
BAX EPS & revenue forecast
EPS · NEXT QUARTER
$0.41
Range $0.35 – $0.51 · 8 analysts · +15% YoY
Next period, 8 analysts expect Baxter International Inc to earn $0.41 a share (range $0.35 – $0.51), versus $0.36 a year earlier. Full-year consensus is $2.11, growing to $2.05 the year after.
REVENUE · NEXT QUARTER
$2.8B
Range $2.8B – $2.8B · 8 analysts · +1% YoY
Revenue is expected to reach $2.8B (range $2.8B – $2.8B), +1.0% year-over-year. Full-year consensus is $11.7B, rising to $12.0B next year.
Top analysts covering Baxter International Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on BAX.
#1
Joanne Wuensch
Citigroup · Rank #35
Neutral
$27.00+3.2% to target
Overall win rate
51%
+ Follow
#2
JB
Jayson Bedford
Raymond James · Rank #191
Neutral
No targeton BAX
Overall win rate
44%
+ Follow
#3
Vijay Kumar
Evercore ISI Group · Rank #331
Buy
$24.00-8.2% to target
Overall win rate
36%
+ Follow
#4
Matt Miksic
Barclays · Rank #543
Buy
$27.00+3.2% to target
Overall win rate
27%
+ Follow
#5
Rick Wise
Stifel
Neutral
$25.00-4.4% to target
Coverage
—
+ Follow
BAX stock forecast FAQ
What is BAX's average 12-month price target?+
The 9 active firms with a live target average $23.56 for Baxter International Inc over the next 12 months, ranging from a $29.00 high to a $15.00 low, as of Nov 19, 2026.
Is BAX stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 9 active firms as of Nov 19, 2026, 1 rate it Buy or Strong Buy, 6 rate it Neutral, and 2 rate it Sell or Strong Sell.
What are the highest and lowest price targets for BAX?+
The Street-high target is $29.00 (TD Cowen), and the Street-low is $15.00 (Morgan Stanley). The average of all 9 active-firm targets is $23.56.
How many active Wall Street firms cover BAX?+
9 active firms have a recognized rating on Baxter International Inc as of Nov 19, 2026, and 9 active firms carry a live 12-month price target.
Who is the most accurate analyst covering BAX?+
Among analysts who currently cover BAX, Joanne Wuensch of Citigroup has the strongest overall Quantellect track record (Rank #35). Their current call is Neutral with a $27.00 target.
What is Baxter International Inc's projected EPS for next quarter?+
The consensus estimate is $0.41 per share (range $0.35 – $0.51) across 8 analysts. Full-year EPS is projected at $2.11, rising to $2.05 the following year.
How much revenue is Baxter International Inc expected to report next quarter?+
Consensus revenue is $2.8B (range $2.8B – $2.8B). Full-year revenue is projected at $11.7B, growing to $12.0B next year.
Have analysts been upgrading or downgrading BAX lately?+
As of Nov 19, 2026, 1 of 9 active firms rate BAX a Buy (6 Neutral, 2 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their BAX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.